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Prothymosin a, an immunoactive polypeptide of 12 kDa, has been isolated from porcine thymus, spleen, lung and kidney. 
It lacks aromatic and sulfur-containing amino acids and has a high content of glutamic and aspartic acids. Tryptic diges- 
tion of porcine thymus prothymosin a yielded peptides which on separation, amino acid analysis and alignment with 
the known sequence of prothymosin a from rat and man showed that the amino terminal portion of the molecule is con- 
served and the few differences present are confined to the carboxy terminal. 
Prothymosin a; Thymic peptide 
1. INTRODUCTION 
ProTa, a highly acidic polypeptide (pZ 3.55), has 
been isolated [l] and sequenced [2] from rat 
thymus and identified in other rat tissues 131. Pro- 
Ta has been sequenced from human thymus [4] 
and identified in leukocytes [5]. The sequence of 
109 amino acids [6] has been deduced from clones 
isolated from a human spleen cDNA library [6] 
and from simian virus 40-transformed human 
fibroblasts [7]. 
The amino acid sequence of the amino terminal 
portion of ProTa from rat and man is identical 
with thymosin ai, a 28-amino acid acidic peptide 
isolated and sequenced from extracts of calf 
thymus, prepared under conditions which did not 
prevent or minimize proteolytic activity [8,9]. 
Prothymosin a is immunoactive. In the human 
autologous MLR rat and porcine ProTa have been 
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shown to be effective in nanogram quantities in 
doubling the magnitude of the response. Further- 
more, these same polypeptides restored to normal 
levels the suboptimal MLR, whereas thymosin al 
had no effect [lo, Ill. In in vivo tests, species dif- 
ferences appear to be confined to the carboxy ter- 
minal of ProTcv [4]. 
The isolation of ProTa from mammals other 
than rat, especially those closer to man and poten- 
tially better sources of this polypeptide, has not 
been reported. In this communication we present 
the purification of ProTa from porcine tissues, 
and the isolation of tryptic fragments by HPLC 
for structure-function studies. 
2. MATERIALS AND METHODS 
Pig tissues from male 5-6-month-old animals (85 kg or over) 
were excised immediately after killing, cut into small pieces, 
frozen in liquid nitrogen and stored at -8O’C until use [l]. 
Synthetic thymosin (~1 1121 was a kind gift from A.M. Felix, and 
fluorescamine was a gift from W.E. Scott, both of Hoffmann- 
La Roche, Nutley, NJ, USA. Sodium boro[3H]hydride, 12.1 
Ci/mmol, was supplied by New England Nuclear. 
Prothymosin LY was assayed by radioimmunoassay as in 
[1,13,14]. The assay was sensitive in the range of 5-150 ng 
thymosin LYI (2-50 pmol). Peptide concentration was deter- 
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mined manually with fluorescamine [15]. Samples for amino 
acid analysis were hydrolysed [l] and analysed as the 
phenylthiocarbamyl derivatives [16]. HPLC was performed on 
Altex Ultrasphere ODS Crs columns, 5 gm (250x 4.6 mm; 
Beckman Instruments), and analytical isoelectric focusing as 
described [ 11. 
Prothymosin cy from thymus, spleen, lung and kidney was 
purified according to Haritos et al. [l], as modified in [17]. 
Briefly, 10 g of unthawed tissue was pulverized in liquid Nz and 
immediately added to 200 ml boiling water. The homogenate 
was sonicated, centrifuged, the supernatant acidified, centri- 
fuged again, the resulting supernatant (acid supernatant) con- 
centrated, and chromatographed on a column of Sephacryl 
S-200, superfine, [1.5 i.d. x90 cm, equilibrated and eluted with 
buffer A (1 M HCOOH/O.Z M pyridine, pH 2.8)], and by 
HPLC (buffer A and I-propanol gradient). 
Tryptic digests of ProTa from thymus were obtained as in 
[2], and chromatographed on HPLC at room temperature. The 
column was equilibrated with buffer A and eluted with a gra- 
dient of the same buffer (solvent A) and 50% acetonitrile in 
buffer A (solvent B) (Haritos, A.A., personal communication). 
The flow rate was 0.6 ml/min, fractions were collected every 
30 s and 0.06 ml aliquots were analyzed by fluorescamine. For 
amino acid analysis, aliquots of 0.05-o. 12 ml were dried direct- 
ly in glass hydrolysis ampoules. 
3. RESULTS AND DISCUSSION 
Acid supernatants from porcine thymus were 
found to contain 124 rg ProTa per g wet tissue, 
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Fig.1. Purification of ProTcv from pig thymus. (A) Gel filtration on Sephacryl S-200 (superfine) column (10 g tissue). (B) HPLC of 
the underlined peak in panel A (equivalent to 5 g tissue). 
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Table 1 
Amino acid composition of prothymosin (Y from porcine tissues 
Amino Thymus Spleen Lung Kidney 
acid ?&SD (n=4) x (n=3) x (n=3) x (n = 2) 
Asx 
GlX 
Ser 
C)Y 
Thr 
Ala 
Arg 
Pro 
Val 
Ile 
Leu 
Lys 
21.2+0.6 25.9 23.2 26.8 
37.5 k-o.9 36.3 34.4 36.9 
2.5 f 0.4 2.4 3.3 2.5 
8.9*0.6 9.4 10.5 9.3 
5.0-+ 1.6 4.8 4.0 5.9 
11210.3 11.7 12.5 11.1 
1.9 k 0.2 2.1 2.2 1.6 
1.4kO.l 2.1 2.8 1.3 
4.4rtO.l 4.5 4.4 4.4 
1.OkO.l 1.3 1.3 0.9 
1.OkO.l 1.3 1.7 0.8 
7.OkO.3 7.0 7.6 7.3 
Total 109.0 108.8 107.9 108.8 
followed by spleen, lung, kidney and liver (75, 66, 
48 and 26 pg, respectively). These results were 
calculated using purified goat thymus ProTa as the 
standard in the radioimmunoassay (Frillingos, S., 
unpublished). 
Purification of ProTa from porcine thymus by 
Sephacryl S-200 (fig.lA) followed by HPLC 
(fig.lB) gave a pure polypeptide with a pZ of 3.5, 
as judged by isoelectric focusing (fig.2). The yield 
from 10 g of thymus was 160 pg of pure ProTa. 
ProTa was also purified from spleen, lung and 
kidney. The amino acid analysis of the top fraction 
from HPLC eluates, including those of thymus, is 
shown in table 1. The analyses how a composition 
rich in glutamic and aspartic acids, poor in 
hydrophobic amino acids and the absence of 
tyrosine, phenylalanine, histidine, tryptophan and 
, T10 
I i Tll 
Elution time (min) 
Fig.3. HPLC of a digest of pig thymus ProTLv (250 fig) with TPCK-trypsin (10 pg). 
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cDNA: 
Tryptic 
peptide: 
Table 2 
Amino acid analysis of peptides from tryptic digestion of porcine thymus ProT&’ 
l-14 15-17 18-20 21-30 31-87 88 89-102 103-109 
TlO T4 Tlb T8, T9 Tll Tlb TS T3 Sum 
Asx 
Glx 
Ser 
GlY 
Thr 
Ala 
Arg 
Pro 
Val 
Ile 
Leu 
LYS 
2.2(2) 
1.1(l) 
2.5(3) 
2.9(3) 
2.2(2) 
1.2(l) 
1.1(l) 
1.0(l) 
2 1.3(l) 1 
1 
3 
3 
2 
1 
1 
1.1(l) 1 
1 1.0(l) 1 
1.1(l) 1 1.1(l) 1 14.7(15) 12 
3.6(4) 4 22.9(23) 26 
0.3(O) 1 
1.3(l) 1 8.9(9) 8 
0.5(l) 1 
1.2(l) 1 7.2(7) 6 
OS(O) 1.0(l) 1 (1) 1 
1.7(2) 1 
1.7(2) 2 1.3(l) 1 
1.5(2) 2 1.0(l) 1 
6.3(6) 6 2.9(3) 3 (28) 
1.9(2) 2 2.0(2)2 (33) 
(3) 
(10). 
1.4(l) 1 (l)cl (6) 
1.9(2) 2 (12) 
(2) 
(2) 
1.1(l) 1 (5) 
(1) 
(1) 
1.8(2) 2 0.6(1)1 (8) 
(14) 14 (3) 3 (3) 3 (10) 10 (59) 57 (1) 1 (14) 14 (7)7 (111) 
aProTa 250 pg. Average of at least two analyses; the last number in each column indicates the number of residues found from the 
sequence of human cDNA 
‘Tl: before hydrolysis, Arg 282 pmol 
‘Thr was present in the composition of T2 (105-109): Asx 3.0, Glx 1.3, Thr 0.81 
Note. Partial or overlapping peptides: T6: Asx 0.7, Glx 0.9, Lys 1.0. T7: Asx 1.1, Glx 1.8, Ala 0.9, Arg 0.9, Val 1.0, Lys 0.4. Peak 
to left of T7 had similar composition to T7 
the sulfur containing amino acids, thus agreeing 
with the results from other species [l-7]. The 
molecular mass for the monomer of 109 amino 
acids was calculated as 12 kDa. 
Tryptic digestion of thymus ProTa and separa- 
tion of the resulting peptides on HPLC gave 11 
peaks (fig.3). Amino acid analysis (table 2) showed 
that each peak contained a single peptide, with the 
exception of peak Tl which in addition contained 
a free arginine. 
Human 
10 20 
AiSDAAVDTSSElTTK DLK EKK EVVEEAENG: DAPANGNA-N:ENGEQEADN:VDEEEEEGG-: 
spleen 
Rat 
thymus 
AcSDAAVDTSSE ITTK DLK EKK EVVEEAEEGR DAPAEGNAQNEENGEQEADNEVDEEEEEGGGE 
Pig 
thymus 
(S~,A,V.B;T.S,S,Z.IJ,T.K) (4Ls< 1 (Z.K,K ,c_Z.V.VZ.Z;&Z.B,G,R) (RA,p.4RG~4~~z,s.~z,z,~,~z,v,s~.z,Zz.ZG.G~, 
110 ---14--11- -111 
-19- 
m Human 
EEEEEEEGD’gEE E- mGDEDE?AEISA(TGK R#EDDEDDDVflKK QK-TDEDD spleen 
dat 
thymus 
Pig.4. Alignment of the amino acid composition of tryptic peptides from pig thymus ProTa with the sequences of ProTLv from human 
spleen [6] and rat thymus [2]. 
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The alignment and comparison of the amino 
acid composition of tryptic peptides with the 
published sequences of ProTa from rat [2] and 
man [4,6,7] is shown in fig.4. It indicates an agree- 
ment in the sequence of ProTa in residues l-30, 
with a heterogeneity in position 28 where peptides 
T8 and T9 have identical composition. Asparagine 
in position 28 is partially deamidated to an aspartic 
residue, thus giving rise to two peptides with iden- 
tical composition on hydrolysis and amino acid 
analysis [2,4,18]. In the sequence 31-109, minor 
but potentially significant [4] changes are 
observed. 
The present study shows that ProTLv is widely 
distributed in pig tissues, as has already been 
shown in rat [3] and in the human [4-71, demon- 
strating that this immunomodulating polypeptide 
is found in lymphoid and non-lymphoid tissues of 
a species closely related to man. It provides a 
source of the polypeptide for in vitro [10,19] and 
in vivo [4] experiments on the maturation and 
modulation of the immune system. 
The conservation in the sequence must have a 
functional significance, since the secondary struc- 
ture of the molecule in aqueous media is a random 
coil [20], a conformation which would not impose 
structural constraints. The fragments obtained by 
tryptic digestion might prove to be of importance 
in understanding this and other relationships be- 
tween structure and function in this molecule. 
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